Poliomyelitis, known as polio, is a highly contagious infectious disease caused by a virus and can lead to paralysis.
Polio vaccination programs have shown to be successful as polio is eliminated in most parts of the world. Measures are being taken to ensure the world both achieves polio eradication and takes the necessary steps to keep it polio-free.
To support these efforts, 2 new oral vaccines have been developed which should be safer than the existing oral vaccines. A clinical study is ongoing in Belgium to evaluate their safety and efficacy.
Two participating sites are searching for two types of healthy volunteers for this polio vaccine study: adults who received the oral polio vaccine (OPV) and adults who received the inactivated polio vaccine (IPV) in their childhood. Given that the IPV is the main vaccination since 1957 in the Netherlands, Dutchmen who are currently living in Belgium can apply for the study.
Akcelis was involved to recruit and pre-qualify this very targeted group of healthy study candidates.
Akcelis launced a multichannel patient recruitment campaign with two-step prequalification: